FDA Investigator Chava Kimchi Sarfaty, PhD
Chava Kimchi Sarfaty, PhD has inspections in 2 countries as of 10 Feb 2023. Chava Kimchi Sarfaty, PhD has collaborated with a combinined 1224 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
10 Feb 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Israel
Co-Investigator(s):
Aaron L Dunbar,
Aikaterini Alexaki,
Andrew "Drew" Haack, PhD,
Andrew Haack, PhD,
Andrew K Haack, PhD,
Anita Narula, PhD,
Barbara Janine Breithaupt,
Brian Janelsins, PhD,
Burnell M Henry,
Caryn M Everly,
Caryn M Mcnab,
CDR Donald Ertel,
Charles Yuanchia Kuo, PhD,
Christopher R Czajka,
Deborah M Trout,
Destry M Sillivan,
Eileen A Liu,
Eliezar Ramos,
Gene D Arcy,
Jacqueline Mdiaz Albertini,
Joan Johnson,
Joyce A Rockwell,
Kathryn E King,
Kirsten L Vadheim, PhD,
LCDR Debra Emerson,
Lewis K Antwi,
Linda Thai,
Lisa K Capron,
Mariza M Jafary,
Melissa J Holz,
Melissa J Ireland,
Michael S Araneta,
Michele L Forster, PhD,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Natalya M Ananyeva,
Nataniel Phillips Sylvain, PhD,
Nicholas Obiri, PhD,
Omotunde O Osunsanmi,
Paula A Trost,
Peter Kessler, PhD,
Prabhu P Raju,
Rabia Ballica, PhD,
Randa Melhem, PhD,
Rebecca K Olin,
Richard Ledwidge (nmi), PhD,
Riley C Myers, PhD,
Riley Meyers,
Robert W Jennings,
Roman Drews, PhD,
Rose M Ashley,
S Lori Brown, PhD MPH,
Simone E Pitts,
Steven E Bowen, PhD,
Susan Yu,
Svetlana A Shestopal,
Teegan Dellibovi Ragheb, PhD,
V Teres Speer,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Wayne E Seifert,
Yideng Liang,
Yuan Chia Kuo,
Ze Peng,
Zhong Li, PhD
Chava Kimchi Sarfaty, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2014 | FDA 483 | AGC Biologics, Inc. - Form 483, 2014-06-06 |
January, 2010 | EIR | GenTrac Inc. - EIR, 2010-01-28 |
June, 2014 | EIR | AGC Biologics, Inc. - EIR, 2014-06-06 |
February, 2020 | FDA 483 | OMRIX BIOPHARMACEUTICALS LTD - Form 483, 2020-02-24 |
January, 2010 | FDA 483 | GenTrac Inc. - Form 483, 2010-01-28 |
January, 2018 | FDA 483 | BAXALTA US INC. - Form 483, 2018-01-19 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more